CEPI collaborates with consortium of Bharat Biotech, University of Sydney and ExcellGene to develop ‘variant-proof’ COVID-19 vaccine Read more
India’s CEPI centralised network lab to assess immunogenicity of COVID-19 vaccine candidates Read more